ammonium tungsten antimonate hydroxide oxide has been researched along with suramin in 10 studies
| Studies (ammonium tungsten antimonate hydroxide oxide) | Trials (ammonium tungsten antimonate hydroxide oxide) | Recent Studies (post-2010) (ammonium tungsten antimonate hydroxide oxide) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
|---|---|---|---|---|---|
| 40 | 2 | 0 | 3,023 | 92 | 431 |
| Protein | Taxonomy | ammonium tungsten antimonate hydroxide oxide (IC50) | suramin (IC50) |
|---|---|---|---|
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
| P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
| DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
| RmtA | Aspergillus nidulans | 5.9 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirsch, MS; Kaplan, JC | 1 |
| Katinka, MD | 1 |
| Matthes, E; Reimer, K; Rosenthal, HA; Scholz, D | 1 |
| Kaplan, JC; Sandström, EG | 1 |
| Broder, S; Yarchoan, R | 1 |
| Sandström, E | 1 |
| Weber, J | 1 |
| Fauci, AS; Lane, HC | 1 |
| Marwick, C; Riesenberg, DE | 1 |
| Rada, B | 1 |
6 review(s) available for ammonium tungsten antimonate hydroxide oxide and suramin
| Article | Year |
|---|---|
Prospects of therapy for infections with human T-lymphotropic virus type III.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication | 1985 |
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Antiviral drugs for AIDS. Current status and future prospects.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1986 |
Immunologic reconstitution in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antimony; Antiviral Agents; Bone Marrow Transplantation; Deltaretrovirus; Humans; Immunotherapy; Interferon Type I; Interferon-gamma; Interleukin-2; Lymphocyte Transfusion; Ribavirin; Suramin; Thymus Gland; Tungsten; Tungsten Compounds | 1985 |
[Experimental chemotherapy of AIDS].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1988 |
4 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and suramin
| Article | Year |
|---|---|
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for?
Topics: Animals; Antimony; Avian Myeloblastosis Virus; Cell Cycle; Centrifugation, Density Gradient; Dose-Response Relationship, Drug; Ethidium; Foscarnet; Magnesium; Manganese; Paramecium; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Suramin; Templates, Genetic; Tungsten; Tungsten Compounds | 1987 |
Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus.
Topics: Animals; Antimony; Antiviral Agents; Cattle; Kinetics; Leukemia Virus, Bovine; Models, Biological; Retroviridae; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Suramin; Tungsten; Tungsten Compounds; Zidovudine | 1989 |
AIDS: the virus, antivirals and vaccines.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine | 1987 |
Anti-AIDS agents show varying early results in vitro and in vivo.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1985 |